Search for: "Wyeth Pharmaceuticals"
Results 601 - 620
of 976
Sort by Relevance
|
Sort by Date
5 Aug 2009, 1:05 pm
The documents suggest the practice went well beyond the case of Wyeth and hormone therapy, involving numerous drugs from other pharmaceutical companies. [read post]
5 Aug 2009, 10:59 am
The documents suggest the practice went well beyond the case of Wyeth and hormone therapy, involving numerous drugs from other pharmaceutical companies. [read post]
5 Aug 2009, 10:06 am
According to the New York Times (click here), court documents demonstrate that ghostwriters paid by Wyeth, a pharmaceutical company, were involved in producing 26 scientific articles. [read post]
5 Aug 2009, 8:05 am
That supposed medical consensus benefited Wyeth, the pharmaceutical company that paid a medical communications firm to draft the papers, as sales of its hormone drugs, called Premarin and Prempro, soared to nearly $2 billion in 2001. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
5 Aug 2009, 1:01 am
According to their Web site, the group's Access to Justice Campaign just won a significant victory against pharmaceutical giant, Wyeth, after a federal court judge granted public access to reams of evidence that the drug maker "ghostwrote" medical journal articles promoting its own dangerous and defective drugs. [read post]
5 Aug 2009, 12:00 am
Recently disclosed court documents reveal that Wyeth, the pharmaceutical giant behind hormone replacement medications Premarin and Prempro,has played a “major role” in 26 scientific articles published backing the medications. [read post]
3 Aug 2009, 7:29 am
.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
31 Jul 2009, 9:55 pm
The conference will allow attendees to: • See how a new global legal paradigm for pharmaceutical patent life cycles is being shaped by forces in the U.S. and abroad; • Understand the interplay between Patent Reform and Follow-on Biologics legislation and how these pending laws will dramatically alter pharmaceutical patent life cycle strategies; •… [read post]
30 Jul 2009, 8:49 pm
In addition to arguing that additional patent term was due in light of Wyeth v. [read post]
30 Jul 2009, 11:32 am
v=dum81RdFrhM&feature=player_embedded Unfortunately, both the manufacturer of Reglan (Wyeth Pharmaceuticals) and manufacturers of the generic metoclopramide (Actavis Elizabeth, Teva Pharmaceuticals USA, Pliva and Barr Pharmaceuticals) have placed profits before patient safety. [read post]
28 Jul 2009, 5:50 pm
Our pharmaceutical injury attorneys help patients and their families hold drug manufacturers legally liable for injuries caused by flaws in their medication, or lack of warning about potentially dangerous side effects. [read post]
27 Jul 2009, 7:41 am
According to the AP, and as reported by the Chicago Tribune, a federal judge has ordered Wyeth Pharmaceuticals to unseal thousands of pages of documents. [read post]
25 Jul 2009, 9:52 am
., granted public access to evidence that Wyeth Pharmaceuticals "ghostwrote" medical articles regarding its hormone therapy drug Prempro, which a national study has shown increases a woman's risk of stroke, heart attack, blood clots, cardiovascular disease, and cancer. [read post]
22 Jul 2009, 10:59 am
As we saw in the Wyeth v. [read post]
20 Jul 2009, 10:00 pm
Already, Wyeth has been interpreted by some as sounding the death knell for the preemption doctrine in the context of pharmaceutical products. [read post]
17 Jul 2009, 3:45 am
The judge in charge of multidistrict litigation involving Wyeth Pharmaceuticals' hormone replacement pill, Prempro, has decided to sanction a law firm representing hundreds of plaintiffs, for its failure to timely produce completed client fact sheets. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
9 Jul 2009, 4:54 am
Merrrell Dow Pharmaceuticals, Inc., 509 U .S. 579 (1993). [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
